期刊文献+

How Much Do We Know about Atopic Asthma: Where Are We Now? 被引量:3

How Much Do We Know about Atopic Asthma: Where Are We Now?
暂未订购
导出
摘要 Asthma is a common disease in the worldwide and it affects over 3.5 million adults and children in the UK. Asthma is a chronic disease characterized by airway hyperresponsiveness, airway inflammation, airway remodelling and reversible airway obstruction. Inflammatory cells, cytokines, chemokines, adhesion molecules, and mediators are involved in pathogenesis of asthma. Chronic airway inflammation and remodelling are the major characters in asthma, which result in decreased pulmonary function. The precise processes are far understood at moment. Although corticosteroid therapy plus other exiting drugs (bronchodilators and oral leukotriene receptor antagonists) influences many different inflammatory and structural cell types and continues to be as the "gold standard" of therapy in asthma, many thousands have chronic, severe diseases and suffer daily symptoms which make their lives a misery. There remains a clear need for novel approaches to therapy, which will be informed by a clearer understanding of disease pathogenesis, particularly in the target organ where airway inflammation and remodelling, the hallmarks of asthma occur. Cellular & Molecular Immunology. Asthma is a common disease in the worldwide and it affects over 3.5 million adults and children in the UK. Asthma is a chronic disease characterized by airway hyperresponsiveness, airway inflammation, airway remodelling and reversible airway obstruction. Inflammatory cells, cytokines, chemokines, adhesion molecules, and mediators are involved in pathogenesis of asthma. Chronic airway inflammation and remodelling are the major characters in asthma, which result in decreased pulmonary function. The precise processes are far understood at moment. Although corticosteroid therapy plus other exiting drugs (bronchodilators and oral leukotriene receptor antagonists) influences many different inflammatory and structural cell types and continues to be as the "gold standard" of therapy in asthma, many thousands have chronic, severe diseases and suffer daily symptoms which make their lives a misery. There remains a clear need for novel approaches to therapy, which will be informed by a clearer understanding of disease pathogenesis, particularly in the target organ where airway inflammation and remodelling, the hallmarks of asthma occur. Cellular & Molecular Immunology.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2006年第5期321-332,共12页 中国免疫学杂志(英文版)
关键词 ATOPY ASTHMA allergic inflammation REMODELLING therapy atopy, asthma, allergic inflammation, remodelling, therapy
  • 相关文献

参考文献12

  • 1Flurina Meiler MSc,Maya Zimmermann MSc,Kurt Blaser PhD,Cezmi A. Akdis MD,Mübeccel Akdis MD, PhD.T-cell subsets in the pathogenesis of human asthma[J].Current Allergy and Asthma Reports.2006(2)
  • 2Lanny J. Rosenwasser,Jianfeng Meng.Anti-CD23[J].Clinical Reviews in Allergy & Immunology.2005(1)
  • 3Wiggs BR,Bosken C,Pare PD,James A,Hogg JC.A model of airway narrowing in asthma and chronic obstructive pulmonary disease[].The American Review of Respiratory Disease.1992
  • 4Tsicopoulos A,Hamid Q,Varney V, et al.Preferential mRNA expression of Th1-type cells (IFN-γ+, IL-2+), in classical delayed-type (tuberculin) hypersensitivity reaction in human skin[].J Immunol.1992
  • 5Cazzola M,Polosa R.Anti-TNF-α and Th1 cytokine-directed therapies for the treatment of asthma[].Current Opinion in Allergy and Clinical Immunology.2006
  • 6Robinson DS,Hamid Q,Ying S, et al.Predominant Th2-type bronchoalveolar lavage T-lymphocyte population in atopicasthma[].The New England Journal of Medicine.1992
  • 7Laitinen A,Altraja A,Kampe M, et al.Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid[].American Journal of Respiratory and Critical Care Medicine.1997
  • 8Izuhara K,Arima K,Kanaji,Ohta S,Kanaji T.IL-13: a promising therapeutic target for bronchial asthma[].Current Medicinal Chemistry.2006
  • 9Kay AB.The role of T lymphocytes in asthma[].Chem Immunol Allergy.2006
  • 10Nakajima H,Iwamoto I,Tomoe S, et al.CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea[].The American Review of Respiratory Disease.1992

同被引文献8

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部